Judge signs off on Bayer's $7.25bn Roundup cancer settlement
A Missouri judge approved Bayer's $7.25bn deal to settle claims that its weedkiller Roundup causes cancer, calling the terms fair. The ruling could close out litigation that has dogged the German company for nearly a decade and knocked 46% off its share price since it bought Monsanto.
- Original source: theguardian.com.
- The source published it on Nov 20, 2026 at 11:42 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
Judge Timothy Boyer of a state court in St Louis signed off Friday on Bayer's $7.25bn settlement of lawsuits alleging its weedkiller Roundup causes cancer. He found the deal was fair, reasonable and adequate. The agreement, announced in February, was designed to resolve nearly all current and future Roundup claims in the US.
Boyer swatted down objections that payments to individual cancer victims would come in too low because claimants who settled earlier got more. He warned that dragging out the payouts could leave victims, including those with terminal cancer, waiting an indeterminate number of years for their money.
Bayer had been staring down roughly 65,000 claims in US state and federal courts from people who said they developed cancer after using Roundup at home or on the job. CEO Bill Anderson called the final approval a decisive milestone in the company's push to shrink the risk from both pending and future Roundup litigation.
The price of that legal fight shows. Bayer's share price has dropped 46% since it bought Monsanto, the maker of the weedkiller, for $63bn in 2018. The company settled much of the Roundup litigation for $10.9bn in 2020, but failed to win court approval for a separate $1.25bn deal covering future claims. Bayer has long insisted Roundup and its active ingredient glyphosate are safe, pointing to decades of studies.
The approval lands five months after the US supreme court tossed a $1.25m jury award for John Durnell, a Missouri man who blamed years of glyphosate exposure for his non-Hodgkin lymphoma. In a 7-2 decision, the court sided with Bayer that a federal pesticide law blocked failure-to-warn claims brought under state law, gutting a key plank of many suits.
Christopher Seeger, a lawyer for many of the plaintiffs, said the Durnell ruling narrowed how Roundup victims can pursue claims in court. He added that he looked forward to getting relief into the hands of all Roundup victims as quickly as possible. Lawyers for some objecting victims did not immediately respond to requests for comment. The settlement leaves out some federal lawsuits still pending; Bayer has said about 200 of those cases remain in litigation and that the supreme court decision handed it strong defenses.
TopicsBayer · Roundup · Monsanto · Bill Anderson · Timothy Boyer · John Durnell · Christopher Seeger · US Supreme Court
Source: theguardian.com
Written by AI from verified reporting.
More stories
- Business & markets x.com 0 viewsGold and the S&P 500 Are Moving in Lockstep as Correlation Doubles
- Business & markets finance.yahoo.com 0 viewsWall Street Wipes Out: Nasdaq Plunges 1,261 Points as AI Stocks Crumble
- Business & markets x.com 1 viewUS pending home sales fall 4.7% in October, now at record-low 63.0
- Business & markets x.com 1 viewPeter Schiff Warns Next Financial Crisis Could Outdo 2008

